261 related articles for article (PubMed ID: 21714721)
1. Antipsychotic-induced hyperprolactinaemia.
Inder WJ; Castle D
Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
8. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
Holt RI; Peveler RC
Clin Endocrinol (Oxf); 2011 Feb; 74(2):141-7. PubMed ID: 20455888
[TBL] [Abstract][Full Text] [Related]
11. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
Smith S; Wheeler MJ; Murray R; O'Keane V
J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
[TBL] [Abstract][Full Text] [Related]
12. The impact of hyperprolactinaemia on sexual function in patients with psychosis.
Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):63-9. PubMed ID: 18477622
[TBL] [Abstract][Full Text] [Related]
13. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
14. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice.
Smith S
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S27-32. PubMed ID: 12832947
[TBL] [Abstract][Full Text] [Related]
15. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
Cookson J; Hodgson R; Wildgust HJ
J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
[TBL] [Abstract][Full Text] [Related]
16. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Howes OD; Smith S; Aitchison KJ
Curr Med Res Opin; 2004 Oct; 20(10):1649. PubMed ID: 15462698
[No Abstract] [Full Text] [Related]
17. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
Stubbs B
J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in schizophrenia: focus on recent evidence.
Baggaley M
Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
[TBL] [Abstract][Full Text] [Related]
19. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire GA
J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia in a patient with a pituitary adenoma receiving antipsychotic drug therapy.
Carroll RW; Christodoulou P; Baynes KC; Kahn DA
J Psychiatr Pract; 2012 Mar; 18(2):126-9. PubMed ID: 22418404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]